What was studied?
Fourteen healthy adults participated in a blinded crossover comparison of defined oral formulations, followed by a short single-arm safety phase.
What did the researchers report?
The micellar preparation produced higher measured blood exposure than the standard preparation under the tested conditions. Short follow-up did not identify significant changes in selected safety markers.
What are the limits?
Small formulation-specific pharmacokinetic findings do not establish long-term clinical benefit. Oral preparations and research-supply materials are not interchangeable.
Original editorial summary by Sulan Peptide. Based on the source abstract; consult the full paper for methods, analyses, funding and disclosures.